Invenio

Emerging Litigation and Corporate Boutiques Create Powerhouse Alliance

Retrieved on: 
Wednesday, March 1, 2023
Zip, Partnership, Partner, GCS, United Kingdom, Invenio, Senior counsel, General counsel, Growth, Lawyer, Partnership for Civil Justice Fund, Private law, BizTech

WASHINGTON and NEW YORK and SYDNEY and LONDON, March 1, 2023 /PRNewswire/ -- American litigation boutique Invenio LLP and emerging global legal consultancy Biztech Lawyers today announced the launch of their cross-border partnership that will now provide an even broader range of legal and strategic business advice to clients who are facing moments of emergence, crisis, or transformation, either as an organization or in navigating new asset classes or markets.

Key Points: 
  • The alliance creates a 'firm of General Counsels' with founders who have served as GCs globally.
  • This partnership offers clients nimble and highly experienced teams that are rate-sensitive and can operate globally from operational bases throughout the United States, Australia, and the United Kingdom.
  • The alliance creates a 'firm of General Counsels' in that it features founders who have each served as highly-regarded General Counsel of leading companies.
  • Indeed, we believe this alliance will be one of a small handful of legal advisors to offer litigation finance transactional capabilities in the major markets of the US, UK, and Australia."

Invenio Imaging Announces Clinical Research Collaboration Agreement

Retrieved on: 
Wednesday, January 4, 2023
Invenio, Johnson & Johnson, Trial of the century, Patient, Food, Entrepreneurship, Biopsy, Food and Drug Administration, CE marking, Multimedia, Lung cancer, Artificial intelligence, Doctor of Philosophy, Medicine, Physician, Research, Cancer, Intelligence, Machine learning, Medical imaging

SANTA CLARA, Calif., Jan. 4, 2023 /PRNewswire/ -- Invenio Imaging, Inc., a leader in intraoperative fresh tissue imaging and artificial intelligence, today announced that it has entered into a research collaboration agreement with the Lung Cancer Initiative at Johnson & Johnson* to develop and validate the NIO® Lung Cancer Reveal image analysis algorithm to assist physicians in the evaluation of bronchoscopic lung biopsies.

Key Points: 
  • SANTA CLARA, Calif., Jan. 4, 2023 /PRNewswire/ -- Invenio Imaging, Inc., a leader in intraoperative fresh tissue imaging and artificial intelligence, today announced that it has entered into a research collaboration agreement with the Lung Cancer Initiative at Johnson & Johnson* to develop and validate the NIO® Lung Cancer Reveal image analysis algorithm to assist physicians in the evaluation of bronchoscopic lung biopsies.
  • "In this important clinical study, we will develop a novel image analysis algorithm based on machine learning to provide physicians with real-time feedback determining whether a biopsy sample contains cancer", says Chris Freudiger, PhD, Co-Founder and CTO of Invenio Imaging.
  • "We are excited to undertake this ambitious clinical study in collaboration with the Lung Cancer Initiative", says Jay Trautman, PhD, Co-Founder and CEO of Invenio Imaging.
  • Invenio Imaging is a medical device start-up based in Santa Clara, CA dedicated to advancing the care of cancer patients by combining intraoperative fresh tissue imaging with artificial intelligence.

Invenio Wealth Partners Joins tru Independence

Retrieved on: 
Thursday, December 1, 2022
Software, Technology, Professional Services, Finance, Growth, RIA, Organization, Partnership, Trust, Sunshine State, RIAS, Financial adviser, Management, Invenio

tru Independence (tru), a $9 billion national independent advisory growth platform, today announced a partnership with Invenio Wealth Partners (Invenio), a $250 million firm based in Coral Gables, Florida.

Key Points: 
  • tru Independence (tru), a $9 billion national independent advisory growth platform, today announced a partnership with Invenio Wealth Partners (Invenio), a $250 million firm based in Coral Gables, Florida.
  • We could not be more impressed with the family office-level of service that Invenio provides its clients, whether theyre ultra-high-net-worth individuals or working families, said Amit Dogra , President and Chief Operating Officer of tru Independence.
  • With its strong sense of fiduciary duty to clients and its ambitious growth plans, Invenio represents a natural addition to the tru platform.
  • Founded in 2014, tru Independence is a leader in delivering independence optimized to established wealth management firms and RIAs seeking to grow their business efficiently and effectively.

Daon Names Ralph Rodriguez as President & Chief Product Officer

Retrieved on: 
Thursday, June 16, 2022
Telecommunications, Software, Networks, Internet, Data Management, Technology, Mobile, Wireless, Security, HST, NTA, Solution, Identity, Census-designated place, MIT Media Lab, Method, SANS Institute, CEO, MIT, SANS, Insurance, Army of the United States, Director, Research, LinkedIn, Growth, Fraud, Trust, IESE Business School, Travel, Brooks Automation, Best Warrior, NASDAQ, CPO, Information, Twitter, Invenio, Computer Incident Advisory Capability, Facebook, Board, Soldier, Anglo-French Wars, Multimedia, AI, Management, Risk management, Technology, Daon

Daon, a global leader in identity assurance technology, announced that Ralph Rodriguez has been named President and Chief Product Officer.

Key Points: 
  • Daon, a global leader in identity assurance technology, announced that Ralph Rodriguez has been named President and Chief Product Officer.
  • View the full release here: https://www.businesswire.com/news/home/20220616005205/en/
    Ralph Rodriguez, Daon President & CPO (Photo: Business Wire)
    Rodriguez has a proven track record over the last 30 years in both early-stage venture-backed companies and large $1B+ publicly held companies.
  • Rodriguez was also the co-founder and chief technology officer of Confirm.io, an identity verification and authentication company acquired by Facebook in March 2018.
  • And based on my observations, Daon is best-in-class in delivering these solutions, added Ralph Rodriguez.

Invenio Imaging Receives CE Mark to Detect Cancer at the Time of Surgery using Artificial Intelligence

Retrieved on: 
Tuesday, May 24, 2022
Invenio, Research, CE marking, Medicine, Doctor of Philosophy, Deep learning, University of Cologne, Patient, Culture, CE, University, CA, Artificial intelligence, CTO, Glioma, Technology, Union, Pathology, Intelligence, Cancer, Medical imaging, Neurosurgery

With the CE mark, neurosurgeons in the European Union can now use NIO Glioma Reveal to inform intraoperative decisions*.

Key Points: 
  • With the CE mark, neurosurgeons in the European Union can now use NIO Glioma Reveal to inform intraoperative decisions*.
  • "Glioma Reveal provides cancer detection where we really need it, dramatically improving brain tumor surgery" Dr. Beck
    "By streamlining intraoperative tissue imaging, the NIO Laser Imaging System allows the imaging of multiple samples from the resection cavity.
  • The NIO Glioma Reveal image analysis module now adds immediate decision support", says Chris Freudiger, PhD, co-founder and CTO of Invenio Imaging.
  • Invenio Imaging is a medical device start-up based in Santa Clara, CA dedicated to advancing the care of cancer patients by combining intraoperative fresh tissue imaging with artificial intelligence.

Private Equity Veterans Launch Claimant-focused Law Firm

Retrieved on: 
Thursday, April 21, 2022
Squire Patton Boggs, Signal, Arnold & Porter, Indigenous peoples, Leadership, Organization, General counsel, Choctaw Nation of Oklahoma, Technology, Arnold, Economic development, Country, Invenio, Lawyer, Partner, Insurance, Tobacco, Indian country, Law firm

Invenio will initially focus on several mass tort cases and will add other claimant and class action mandates over time.

Key Points: 
  • Invenio will initially focus on several mass tort cases and will add other claimant and class action mandates over time.
  • The firm is also building out technology driven client engagement capabilities with the collaboration of experienced technologists.
  • The firm is among the first Native American-owned law firms to focus primarily on plaintiff-side litigation matters.
  • The firm also features corporate advisory and strategic solutions/crisis management practices that draw on the founders' decades of experience in high stakes "turning points" for companies and markets and as in-house legal leaders in private equity.

Invenio Imaging Celebrates 2000th NIO Laser Imaging System case

Retrieved on: 
Tuesday, October 12, 2021
OR, CE marking, Neurosurgery, Marie Cassidy, Histology, Doctor of Philosophy, Pleasure, Stimulated Raman spectroscopy, Invenio, Surgeon, NIO, Entrepreneurship, Architecture, Surgical oncology, Review, Hospital, Pathology, CA, CEO, CTO, Congress, Patient, Microscope, Medical imaging

SANTA CLARA, Calif., Oct. 12, 2021 /PRNewswire/ -- Invenio Imaging is proud to announce the 2000th case with the NIO Laser Imaging System, which uses Stimulated Raman Histology to provide microscopic images of fresh tissue specimens in minutes.

Key Points: 
  • SANTA CLARA, Calif., Oct. 12, 2021 /PRNewswire/ -- Invenio Imaging is proud to announce the 2000th case with the NIO Laser Imaging System, which uses Stimulated Raman Histology to provide microscopic images of fresh tissue specimens in minutes.
  • With the NIO Laser Imaging System it is possible, for the first time, to quickly get access to cellular information at the time of surgery and make more informed surgical decisions," said Dr. Dan Orringer, neurosurgeon.
  • "I vividly remember the first case in Dr. Orringer's OR in 2015 with the instrument that would become the NIO Laser Imaging System," said Chris Freudiger, PhD, Co-Founder and CTO of Invenio Imaging, "Seeing this system in use in hospitals across the US and Europe is an exciting story of clinical translation.
  • Invenio Imaging, based in Santa Clara, CA has developed and manufactures the NIO Laser Imaging System.

Invenio Imaging receives CE Mark for NIO Laser Imaging System

Retrieved on: 
Tuesday, September 28, 2021
Invenio, University, Neurosurgery, Brain, Review, University of Cologne, Diagnosis, Histology, Surgeon, Pathology, IVDD, OR, Thermal laser stimulation, Quality, United States, CA, Technology, NIO, United, CE marking, Medicine, Medical device, Medical imaging

SANTA CLARA, Calif., Sept. 28, 2021 /PRNewswire/ -- Invenio Imaging announced today that it has obtained the CE Mark for the NIO Laser Imaging System according to the In Vitro Diagnostic Directive (IVDD).

Key Points: 
  • SANTA CLARA, Calif., Sept. 28, 2021 /PRNewswire/ -- Invenio Imaging announced today that it has obtained the CE Mark for the NIO Laser Imaging System according to the In Vitro Diagnostic Directive (IVDD).
  • This enables commercialization of this novel imaging system for intraoperative histology in the European market.
  • "The NIO Laser Imaging System represents an outstanding technique revolutionizing fast and precise intraoperative diagnosis of brain tumors," said Prof. Dr. Georg Widhalm, neurosurgeon at the University of Vienna.
  • Invenio Imaging, based in Santa Clara, CA has developed and manufactures the NIO Laser Imaging System.

Invenio Imaging receives CE Mark for NIO Laser Imaging System

Retrieved on: 
Tuesday, September 28, 2021
Invenio, University, Neurosurgery, Brain, Review, University of Cologne, Diagnosis, Histology, Surgeon, Pathology, IVDD, OR, Thermal laser stimulation, Quality, United States, CA, Technology, NIO, United, CE marking, Medicine, Medical device, Medical imaging

SANTA CLARA, Calif., Sept. 28, 2021 /PRNewswire/ -- Invenio Imaging announced today that it has obtained the CE Mark for the NIO Laser Imaging System according to the In Vitro Diagnostic Directive (IVDD).

Key Points: 
  • SANTA CLARA, Calif., Sept. 28, 2021 /PRNewswire/ -- Invenio Imaging announced today that it has obtained the CE Mark for the NIO Laser Imaging System according to the In Vitro Diagnostic Directive (IVDD).
  • This enables commercialization of this novel imaging system for intraoperative histology in the European market.
  • "The NIO Laser Imaging System represents an outstanding technique revolutionizing fast and precise intraoperative diagnosis of brain tumors," said Prof. Dr. Georg Widhalm, neurosurgeon at the University of Vienna.
  • Invenio Imaging, based in Santa Clara, CA has developed and manufactures the NIO Laser Imaging System.